- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:26 | FDA approves BeiGene's TEVIMBRA combo for treating certain gastric cancers | ||
| Fr | Axcelead DDP and Astellas partner for targeted protein degrader discovery | ||
| Do | Bio-Thera and Tabuk partner for Stelara biosimilar in Saudi Arabia | ||
| Di | Basilea receives additional funding from CARB-X to advance antibiotic candidate | ||
| 23.12. | WuXi Biologics and Hangzhou DAC sign ADC agreement | ||
| 20.12. | Assembly Bio and Gilead collaborate to advance antiviral therapeutic programmes | ||
| 19.12. | Agios announces EC's positive decision for sickle cell disease therapy designation | ||
| 18.12. | Akamis secures funds to advance cancer therapy through study | ||
| 17.12. | Candid partners with EpimAb to develop T-cell engager candidates | ||
| 16.12. | Sanofi's multiple sclerosis therapy gains breakthrough therapy status from FDA | ||
| 13.12. | Tanner-Agenus partner for expanded access to immunotherapies for cancer patients | ||
| 12.12. | ProQR expands partnership with RSRT to advance Rett Syndrome therapy | ||
| 11.12. | Orthogon secures funding to boost BK virus treatments for transplant patients | ||
| 10.12. | FDA accepts Crinetics Pharmaceuticals' NDA for acromegaly treatment therapy | ||
| 09.12. | Torii submits NDA for molluscum contagiosum treatment therapy in Japan | ||
| 06.12. | MindMed receives innovation passport for GAD therapy from UK MHRA | ||
| 05.12. | Theratechnologies to license Ionis' RNA-targeted therapies in Canada | ||
| 04.12. | Gilead and Tubulis sign ADC development deal for cancer treatment | ||
| 03.12. | Japan MHLW grants orphan drug status to Renalys' sparsentan for IgAN treatment | ||
| 02.12. | Hong Kong regulator accepts Everest's ulcerative colitis therapy NDA | ||
| 29.11. | Dr. Reddy's Laboratories introduces Toripalimab in India for nasopharyngeal carcinoma | ||
| 28.11. | China's NMPA grants marketing approval to Kelun-Biotech's sac-TMT for TNBC treatment | ||
| 27.11. | Valneva submits application seeking FDA approval for IXCHIQ for adolescent use | ||
| 26.11. | FDA accepts Alnylam's vutrisiran sNDA to treat ATTR-CM | ||
| 25.11. | FDA approves StemCyte's cord blood stem cell therapy BLA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
